MJ, K., C, C., I, R., O, G., M, E., S, H., . . . WP, F. (2026). New prostate cancer risk groups by PSMA-PET (PPP3): An international, retrospective, registry-based cohort study. The Lancet. Oncology, 27(4), 480. https://doi.org/10.1016/S1470-2045(26)00016-1
Chicago Style (17th ed.) CitationMJ, Karpinski, et al. "New Prostate Cancer Risk Groups by PSMA-PET (PPP3): An International, Retrospective, Registry-based Cohort Study." The Lancet. Oncology 27, no. 4 (2026): 480. https://doi.org/10.1016/S1470-2045(26)00016-1.
MLA (9th ed.) CitationMJ, Karpinski, et al. "New Prostate Cancer Risk Groups by PSMA-PET (PPP3): An International, Retrospective, Registry-based Cohort Study." The Lancet. Oncology, vol. 27, no. 4, 2026, p. 480, https://doi.org/10.1016/S1470-2045(26)00016-1.